Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levente Szalárdy

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Expert Opinion on Investigational Drugs|September 29, 2016
Investigational α-synuclein aggregation inhibitors: hope for Parkinson's diseaseNóra Török, Zsófia Majláth, Levente Szalárdy, et al.
The Journal of Headache and Pain|March 11, 2018
PACAP and its role in primary headachesLars Edvinsson, János Tajti, Levente Szalárdy, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal DiagnosisLevente Szalárdy, Dénes Zádori, Péter Klivényi, et al.
Nature Reviews. Drug Discovery|December 15, 2012
Kynurenines in the CNS: recent advances and new questionsLászló Vécsei, Levente Szalárdy, Ferenc Fülöp, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and KynureninesDénes Zádori, Gábor Veres, Levente Szalárdy, et al.
Ideggyogyaszati Szemle|February 22, 2014
Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in miceImola Plangár, Dénes Zádori, Levente Szalárdy, et al.
Expert Opinion on Drug Safety|May 19, 2015
Drug-induced movement disordersDénes Zádori, Gábor Veres, Levente Szalárdy, et al.
Oxidative Medicine and Cellular Longevity|August 25, 2015
Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsLevente Szalárdy, Dénes Zádori, Péter Klivényi, et al.
Journal of the Neurological Sciences|July 4, 2012
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disordersDénes Zádori, Péter Klivényi, Levente Szalárdy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 1, 2012
Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's diseaseDénes Zádori, Levente Szalárdy, József Toldi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|September 29, 2016
Investigational α-synuclein aggregation inhibitors: hope for Parkinson's diseaseNóra Török, Zsófia Majláth, Levente Szalárdy, et al.
The Journal of Headache and Pain|March 11, 2018
PACAP and its role in primary headachesLars Edvinsson, János Tajti, Levente Szalárdy, et al.
Journal of Alzheimer'S Disease : JAD|May 11, 2016
The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal DiagnosisLevente Szalárdy, Dénes Zádori, Péter Klivényi, et al.
Nature Reviews. Drug Discovery|December 15, 2012
Kynurenines in the CNS: recent advances and new questionsLászló Vécsei, Levente Szalárdy, Ferenc Fülöp, et al.
Journal of Alzheimer'S Disease : JAD|February 27, 2018
Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and KynureninesDénes Zádori, Gábor Veres, Levente Szalárdy, et al.
Ideggyogyaszati Szemle|February 22, 2014
Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in miceImola Plangár, Dénes Zádori, Levente Szalárdy, et al.
Expert Opinion on Drug Safety|May 19, 2015
Drug-induced movement disordersDénes Zádori, Gábor Veres, Levente Szalárdy, et al.
Oxidative Medicine and Cellular Longevity|August 25, 2015
Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial BioenergeticsLevente Szalárdy, Dénes Zádori, Péter Klivényi, et al.
Journal of the Neurological Sciences|July 4, 2012
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disordersDénes Zádori, Péter Klivényi, Levente Szalárdy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 1, 2012
Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's diseaseDénes Zádori, Levente Szalárdy, József Toldi, et al.
Pageof 2